ADHD Medication 101: What a psychological evaluation recommends, and what it doesn't
One of the most common questions I get at the end of an evaluation is some version of: "So does this mean I need medication?" It's a reasonable question, and the answer is more nuanced than most people expect. A psychological evaluation is not a prescription. It's not a referral to a specific medication. And it's not a recommendation that anyone take any particular treatment path. What it is, when done well, is the clearest possible picture of what's actually going on, which turns out to be the most useful thing you can have when making decisions about medication with the clinician who can actually prescribe it.
Understanding what an evaluation does and doesn't do in the treatment pipeline reduces a lot of confusion and a lot of anxiety about the process.
What a psychological evaluation actually produces
A comprehensive psychological evaluation for ADHD produces a detailed clinical picture: the specific presentation of ADHD, whether inattentive, hyperactive, or combined, the severity of symptoms across different domains, the cognitive profile that underlies the symptoms, any co-occurring conditions that are present and need to be accounted for, and the functional impact of all of the above on the person's daily life. It produces a written report with that clinical picture documented, and a set of recommendations that follow from it.
Those recommendations will typically include a range of options: types of therapeutic support that are evidence-based for ADHD, accommodations that are appropriate for the school or work setting, strategies that are likely to help given the specific profile, and, often, a recommendation that the person discuss medication options with a prescribing clinician. That last one is a recommendation to have a conversation, not a recommendation for a specific drug or dose.
Psychologists in California, like in most states, cannot prescribe medication. The evaluation provides the clinical foundation that makes a medication conversation with a prescriber more informed and more productive. It doesn't replace that conversation or predetermine its outcome.
Why the evaluation matters for the medication conversation
A lot of people go to a prescriber for ADHD medication with little more than a list of symptoms and a suspicion. That's not nothing, and prescribers work with it. But a comprehensive evaluation report gives the prescriber something substantially more useful: documented evidence of the specific ADHD presentation, cognitive data that contextualizes the symptoms, information about co-occurring conditions that affect medication choices, and a clinical picture that helps distinguish ADHD from the many other conditions that can produce similar symptoms.
Co-occurring conditions are particularly important here. ADHD frequently coexists with anxiety, depression, learning disabilities, autism, and sleep disorders, all of which can affect how stimulant medication works and what additional support is needed alongside it. A person whose ADHD is accompanied by significant anxiety may respond differently to stimulant medication than a person whose ADHD is relatively uncomplicated. A person with both ADHD and autism has a profile that requires more careful clinical attention than either condition alone. The evaluation surfaces all of this in a way that a brief prescribing appointment typically can't.
"My prescriber told me the evaluation report was the most detailed clinical picture she'd seen in years. She said it changed which medication she recommended and why. I hadn't realized the two things were connected."
What ADHD medication does and doesn't do
Stimulant medications, which include the amphetamine-based medications like Adderall and the methylphenidate-based medications like Ritalin and Concerta, are the most extensively researched psychiatric medications that exist. The evidence base for their effectiveness in ADHD is robust and consistent across decades of research. For many people with ADHD, stimulant medication produces meaningful improvement in attention regulation, impulse control, working memory, and the ability to initiate and sustain tasks.
What medication doesn't do is teach skills, build habits, or address the years of secondary effects that ADHD has produced. A person who has spent twenty years developing shame, avoidance patterns, and negative self-beliefs around their ADHD doesn't have those things resolved by medication that improves their executive function. The medication creates conditions under which those things can be addressed. The addressing still requires effort, usually with therapeutic support.
Non-stimulant medications are also available and appropriate for some people, particularly those who don't respond well to stimulants, have certain cardiac or anxiety conditions that make stimulants less suitable, or have a history of substance use that makes stimulant prescribing more complicated. Atomoxetine, guanfacine, and clonidine are among the non-stimulant options with reasonable evidence bases. The prescriber is the right person to navigate these choices with, with the evaluation report as the clinical foundation.
The people who aren't sure they want medication
A significant portion of the adults I evaluate are genuinely uncertain about medication. Some have concerns about side effects, about dependence, or about what it means about them to need medication to function the way they want to function. Some have tried medication before and had a bad experience. Some are philosophically uncertain about medicating neurological differences rather than accommodating them structurally.
All of these are legitimate positions that deserve a real conversation rather than a dismissal. Medication is not the only useful intervention for ADHD. Behavioral strategies, executive function coaching, environmental accommodations, therapy that addresses the psychological consequences of ADHD, and structural changes to work and home environments all have genuine evidence behind them. Many people use a combination of medication and non-medication approaches. Some people manage well without medication. The right path depends on the severity of the impairment, the person's circumstances, and their own values and preferences.
What a comprehensive evaluation does is give that conversation a solid foundation. You know what you're dealing with specifically. You know the severity. You know what's co-occurring. You know what the functional impact is. From that foundation, the conversation with a prescriber or therapist about what to do next is substantially more informed than it would be otherwise.
Who to see after an evaluation
For adults seeking ADHD medication in California, the most common routes are through a psychiatrist, who specializes in psychiatric medication and can manage complex cases and co-occurring conditions, or through a primary care physician or nurse practitioner who is comfortable prescribing for ADHD. Psychiatrists tend to be more appropriate when the clinical picture is complex, when co-occurring conditions are significant, or when previous medication trials haven't gone well. Primary care is often adequate for straightforward presentations, though access to psychiatry has improved with the expansion of telehealth.
For children, a developmental pediatrician or child psychiatrist is typically the right prescriber. Pediatricians who are comfortable with ADHD often manage medication for children with straightforward profiles as well.
The evaluation report travels with you to whichever prescriber you see. It gives them what they need to make an informed recommendation rather than starting from scratch. That efficiency matters, and so does the accuracy of the clinical picture it provides. Getting the evaluation right is what makes everything that comes after it easier.
Frequently asked questions
Q: Do I have to take medication if I get an ADHD diagnosis?
A: No, and a diagnosis doesn't obligate you to any particular treatment path. Medication is one well-evidenced option among several, and the right approach depends on the severity of your ADHD, your circumstances, your values, and what you're trying to address. Some people manage well with a combination of behavioral strategies, executive function coaching, accommodations, and therapy. Others find that medication makes those other approaches significantly more accessible. The evaluation gives you an accurate picture of what you're working with. What you do with that picture is a conversation between you and the clinicians you work with, not a predetermined outcome of the diagnosis itself.
Q: Can my primary care doctor prescribe ADHD medication, or do I need a psychiatrist?
A: In California, primary care physicians and nurse practitioners can and do prescribe ADHD medication for straightforward cases. A psychiatrist is generally more appropriate when the clinical picture is complex, when significant co-occurring conditions are present, when previous medication trials haven't gone well, or when the diagnostic picture isn't fully clear. A comprehensive evaluation report helps any prescriber make a more informed decision regardless of their specialty, but it's particularly useful for primary care providers who may have limited time to gather detailed clinical history. If your evaluation identifies significant co-occurring conditions alongside ADHD, asking for a psychiatry referral rather than going straight to primary care is often worth it.
Q: I had a bad experience with ADHD medication in the past. Does that mean it won't work for me?
A: Not necessarily. ADHD medication trials that don't go well are often a matter of the wrong medication, the wrong dose, or an unidentified co-occurring condition that affected the response. Stimulants come in multiple formulations and delivery mechanisms, and the methylphenidate class and amphetamine class work through somewhat different mechanisms, which means a poor response to one doesn't predict a poor response to the other. Non-stimulant options exist for people who don't tolerate stimulants well. A comprehensive evaluation that documents co-occurring conditions and provides a full clinical picture often makes the difference between a prescriber who is guessing and one who has a real basis for a more targeted recommendation. A bad first experience is worth revisiting with better information rather than treating as a final answer.
Q: Will a psychological evaluation tell me which medication to take?
A: No, and it shouldn't — that's the prescriber's role, not the evaluator's. What the evaluation does is give the prescriber a detailed, documented clinical picture that makes their medication decisions more informed. It identifies the specific ADHD presentation and severity, documents co-occurring conditions that affect medication choices, provides cognitive data that contextualizes the symptoms, and distinguishes ADHD from other conditions that can look similar. The prescriber takes all of that and applies their clinical judgment about what to try first and how to titrate it. The two roles are complementary rather than overlapping, and having both done well produces better outcomes than either alone.
